T0	Participants 37 76	acromegalic patients with macroadenomas
T1	Participants 273 329	newly diagnosed acromegalic patients with macroadenomas.
T2	Participants 840 860	pool of 108 patients
T3	Participants 978 1003	49 patients in each group
T4	Participants 1655 1706	patients with GH-secreting pituitary macroadenomas.